UOC
AGN

UBS O'Connor’s Allergan plc AGN Stock Holding History

UBS O'Connor’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-281,112
Closed -$47.1M – 378
2019
Q2 		$47.1M Buy
+281,112
New +$38.9M 0.91% 21
2017
Q3 		– Sell
-3,800
Closed -$924K – 484
2017
Q2 		$924K Buy
+3,800
New +$893K 0.02% 313
2016
Q2 		– Sell
-528,403
Closed -$142M – 548
2016
Q1 		$142M Buy
528,403
+470,898
+819% +$135M 1.41% 13
2015
Q4 		$18M Buy
+57,505
New +$17.1M 0.16% 126
2015
Q3 		– Sell
-2,890
Closed -$876K – 830
2015
Q2 		$876K Buy
2,890
+2,155
+293% +$643K 0.01% 619
2015
Q1 		$219K Buy
+735
New +$210K ﹤0.01% 719
2013
Q3 		– Sell
-29,000
Closed -$3.66M – 605
2013
Q2 		$3.66M Buy
+29,000
New +$3.28M 0.07% 270

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

UBS O'Connor's AGN Position: Q3 2019 in Review

UBS O'Connor sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 281,112 shares — an estimated $47.1M sold.

UBS O'Connor first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $142M in Q1 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • UBS O'Connor reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • UBS O'Connor sold 281,112 Allergan plc shares in Q3 2019, an estimated $47.1M.
  • UBS O'Connor first reported a position in Allergan plc in Q2 2013 and held it in 7 quarters.
  • UBS O'Connor's Allergan plc position peaked at $142M in Q1 2016.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on UBS O'Connor's 13F filing for Q3 2019, filed 14 Nov 2019.